Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-22-000011

Options or other derivatives

  • Director acquired 20,239 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Miller Joseph M · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,239 20,239 D
Loading xslF345X03/primary_doc.xml…